Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis.
Send us all your questions or requests, and our expert team will assist you.
This Overview and Definition provides a clear picture of liver cancer, a disease that affects one of the body’s most vital organs. Liver cancer accounts for approximately 8% of all new cancer cases worldwide, and early detection dramatically improves outcomes. The page is designed for patients and families seeking reliable information, as well as international visitors planning treatment at Liv Hospital. We will explore the disease’s biology, risk factors, clinical presentation, diagnostic pathways, and therapeutic options, ensuring you have a solid foundation to discuss care plans with your medical team.
Understanding the fundamentals of liver cancer empowers you to make informed decisions, navigate complex treatment choices, and engage proactively in your health journey. Throughout this guide, you will find concise explanations, helpful tables, and actionable lists that simplify even the most technical aspects of the disease.
When we talk about liver cancer, it is essential to differentiate between its primary forms and how they are staged. The two main primary liver cancers are hepatocellular carcinoma (HCC) and cholangiocarcinoma, each arising from different cell types within the liver. Staging determines the extent of tumor spread and guides treatment selection.
Staging systems such as the Barcelona Clinic Liver Cancer (BCLC) classification combine tumor size, liver function, and patient performance status. Early-stage disease (BCLC 0‑A) may be eligible for curative therapies like resection or ablation, whereas intermediate and advanced stages (BCLC B‑D) often require systemic or palliative approaches.
This overview and definition of liver cancer types and staging lays the groundwork for understanding subsequent sections on causes, symptoms, and treatment.
Identifying the underlying causes of liver cancer helps target prevention and early‑detection strategies. While some risk factors are unavoidable, many are modifiable through lifestyle changes and medical interventions.
Environmental exposures, including certain industrial chemicals (e.g., vinyl chloride), also raise the likelihood of rare liver cancers like angiosarcoma. Regular screening for hepatitis B and C, vaccination, and limiting alcohol intake are proven measures to reduce risk.
Our overview and definition of causes emphasizes that many risk factors are identifiable, allowing clinicians to implement surveillance programs for high‑risk individuals.
Liver cancer often remains silent in its early stages, making awareness of subtle signs crucial for timely diagnosis. Symptoms usually emerge as the tumor enlarges or impairs liver function.
Because these symptoms overlap with many benign liver conditions, any persistent sign warrants further evaluation, especially in individuals with known risk factors.
This overview and definition of symptoms equips patients to recognize warning signs early and seek appropriate medical attention.
Accurate diagnosis of liver cancer relies on a combination of imaging, laboratory studies, and sometimes tissue sampling. Modern diagnostics aim to stage disease precisely while minimizing invasiveness.
In many cases, a combination of imaging and AFP levels can establish a diagnosis without biopsy, reducing procedural risk. Staging work‑up may also include chest CT and bone scans to detect distant metastases.
This overview and definition of diagnostic pathways highlights the comprehensive, evidence‑based approach employed at Liv Hospital.
Treatment for liver cancer is highly individualized, depending on tumor stage, liver function, and patient health. Options range from curative surgery to systemic therapies and clinical trials.
Liv Hospital integrates state‑of‑the‑art robotic surgery, precision radiotherapy, and access to international clinical trials, ensuring patients receive the most advanced care available.
Beyond medical treatment, comprehensive support services are vital for quality of life. Survivorship programs address physical, emotional, and logistical challenges faced by patients and families.
Liv Hospital’s 360‑degree patient assistance program ensures that every aspect of the journey—from pre‑admission paperwork to post‑treatment follow‑up—is handled with professionalism and compassion.
Liv Hospital is a JCI‑accredited, internationally recognized center that specializes in comprehensive cancer care for patients traveling from abroad. Our multidisciplinary team combines expertise in hepatology, oncology, surgery, and radiology to deliver personalized treatment plans. International patients benefit from dedicated concierge services, including airport transfers, multilingual interpreters, and comfortable accommodation options, allowing them to focus solely on recovery.
Take the first step toward expert liver cancer care. Contact Liv Hospital today to schedule a virtual consultation and learn how our international patient program can simplify your treatment journey.
Send us all your questions or requests, and our expert team will assist you.
Primary liver cancer originates within the liver itself. Hepatocellular carcinoma (HCC) arises from hepatocytes and is strongly linked to cirrhosis, hepatitis B or C, and alcohol abuse. Cholangiocarcinoma develops from the bile duct cells and is associated with conditions such as primary sclerosing cholangitis and liver fluke infection. A third, much rarer form is angiosarcoma, which stems from the blood‑vessel lining and is linked to exposure to chemicals like vinyl chloride. Each type presents with distinct risk profiles and may require different therapeutic approaches, making accurate classification essential for optimal patient management.
Staging determines how far the tumor has spread and guides treatment selection. The BCLC system categorizes patients from very early (0) to terminal (D) stages based on tumor burden, liver reserve (Child‑Pugh score), and overall health. Early‑stage disease (BCLC 0‑A) may be eligible for curative options such as surgical resection, liver transplantation, or radiofrequency ablation. Intermediate stages (BCLC B) often receive transarterial chemoembolization (TACE) to control disease, while advanced stages (BCLC C‑D) are managed with systemic therapies like sorafenib or immunotherapy. Accurate staging ensures patients receive the most effective, evidence‑based care while avoiding unnecessary procedures.
Chronic infection with hepatitis B virus (HBV) is the leading global cause of liver cancer, followed by hepatitis C virus (HCV) especially in Western countries. Long‑term alcohol abuse can lead to cirrhosis, a major pre‑cancerous condition. Metabolic diseases such as non‑alcoholic fatty liver disease (NAFLD) and diabetes increase risk through chronic inflammation. Environmental toxins like aflatoxins, produced by molds in improperly stored grains, are potent carcinogens. Genetic conditions such as hemochromatosis and Wilson’s disease also predispose individuals. Recognizing these factors enables targeted screening and preventive strategies, such as vaccination for HBV and lifestyle modifications.
Early liver cancer often produces no symptoms, but as the tumor grows, patients may notice weight loss, loss of appetite, and persistent upper‑abdominal discomfort. Jaundice—yellowing of the skin and eyes—indicates impaired bile flow. Fluid accumulation in the abdomen (ascites) and swelling can result from portal hypertension. Pruritus (itching) occurs due to bile salt buildup, while fatigue and weakness are common nonspecific complaints. In advanced disease, fever or night sweats may appear. Because these signs overlap with benign liver conditions, anyone with persistent symptoms—especially if they have known risk factors—should seek medical evaluation promptly.
When the tumor is small, confined to the liver, and the patient has adequate liver function, surgical resection offers the best chance of cure by removing the tumor entirely. For patients with early disease who also have cirrhosis meeting the Milan criteria, liver transplantation provides both tumor removal and replacement of the diseased liver, leading to excellent long‑term survival. Radiofrequency ablation (RFA) is a minimally invasive option for tumors less than 3 cm, delivering heat to destroy cancer cells and preserving more liver tissue. In select cases, percutaneous ethanol injection or newer techniques like microwave ablation are used. Multidisciplinary evaluation ensures the most appropriate curative approach is selected based on tumor characteristics and patient health.
Your Comparison List (you must select at least 2 packages)
